Total pharmaceutical sales in South Korea are projected to increase steadily from 2024 to 2028. In 2023, sales stood at 867.0 US Dollars PPP per capita. Year-on-year growth rates are as follows:
- 2024: 4.4%
- 2025: 4.4%
- 2026: 4.2%
- 2027: 3.6%
- 2028: 3.9%
The compound annual growth rate (CAGR) for the 2024-2028 period is estimated to be 4.1%.
Looking ahead, it will be important to monitor advancements in digital healthcare, government healthcare policies, and rising elderly populations which may influence pharmaceutical demand. Additionally, tracking innovation within the biotech sector and the pharmaceutical industry's shift towards personalized medicine will be essential in understanding future market dynamics.
